According to KYORIN Pharmaceutical's latest financial reports the company's current earnings (TTM) are $43.33 M. In 2022 the company made an earning of $59.48 M an increase over its 2021 earnings that were of $51.56 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $43.33 M | -27.15% |
2022 | $59.48 M | 15.34% |
2021 | $51.56 M | -35.57% |
2020 | $80.04 M | 5.44% |
2019 | $75.91 M | 8.42% |
2018 | $70.01 M | -32.11% |
2017 | $0.10 B | 7.21% |
2016 | $96.19 M | -37.32% |
2015 | $0.15 B | -7.12% |
2014 | $0.16 B | -9.87% |
2013 | $0.18 B | -12.01% |
2012 | $0.20 B | -6.41% |
2011 | $0.22 B | 33.59% |
2010 | $0.16 B | 9.93% |
2009 | $0.15 B |